Theragnostics, GE Healthcare announce prostate cancer diagnostic partnership
admin 9th October 2019 Uncategorised 0Theragnostics will lead the development of the tracer, GalliProst, while GE Healthcare will lead all pre-approval commercial preparations.
More: Theragnostics, GE Healthcare announce prostate cancer diagnostic partnership
Source: News